Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

New study tests ZoMaxx drug-eluting coronary stent

Sep. 16, 2004

Protective cardiovascular effects of prostaglandin E2 receptor subtype EP4 agonist

Sep. 16, 2004

Therapeutic benefits of statins in patients with CHD and metabolic syndrome

Sep. 16, 2004

Eurand to develop modified-release lercanidipine for Recordati

Sep. 14, 2004

Phase IIb study evaluates VEGF-2 for severe cardiovascular disease

Sep. 13, 2004

Ventavis NDA accepted for priority review

Sep. 13, 2004

Enrollment target reached in STRIDE-2 study of Thelin

Sep. 13, 2004

FR-183998 shows beneficial effects in porcine pancreas allotransplantation model

Sep. 10, 2004

Sitaxsentan improves performance of PAH patients failing bosentan therapy

Sep. 10, 2004

New Na+/Ca2+ exchanger inhibitors and their use as antiarrhythmic agents

Sep. 8, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...